首页>
外国专利>
TREATMENT OF AUTOIMMUNE DISEASES IN PATIENT SUFFERING FROM INADEQUATE RESPONSE TO TNF-ALPHA INHIBITOR
TREATMENT OF AUTOIMMUNE DISEASES IN PATIENT SUFFERING FROM INADEQUATE RESPONSE TO TNF-ALPHA INHIBITOR
展开▼
机译:对TNF-α抑制剂反应不足的患者的自身免疫性疾病的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: group of inventions refers to medicine, particularly to immunology, and concerns treatment of rheumatoid arthritis associated with inadequate response to TNF-alpha inhibitor. The treatment is ensured by intravenous introduction of antibodies bound with CD20, particularly humanised 2H7v16, containing variable domains presented with SEQ ID Nos. 1 and 2. Antibodies are injected intravenously in dosage 1000 mg twice.;EFFECT: effective treatment of arthritis associated with inadequate response to TNF-alpha inhibitor due to introduction regimen developed by the applicant, extension of range of medical products for treatment of said pathology.;2 cl, 1 tbl, 1 ex
展开▼
机译:领域:发明领域本发明涉及药物,特别是涉及免疫学,并且涉及与对TNF-α抑制剂反应不足有关的类风湿性关节炎的治疗。通过静脉内导入与CD20结合的抗体(特别是人源化2H7v16)来确保治疗,该抗体含有SEQ ID Nos。1和2所示的可变域。抗体以1000 mg的剂量静脉内注射两次;效果:有效治疗与不足有关的关节炎由于申请人开发的引入方案对TNF-α抑制剂的反应,扩大了用于治疗所述病理的医疗产品范围。; 2 cl,1 tbl,1 ex
展开▼